Reading HAE? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track HAE free→Reading HAE? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track HAE free→QuarterlyIQ Insights · HAE
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Results of Operations and Financial Condition. On May 7, 2026, Haemonetics Corporation issued a press release announcing financial results for the fourth quarter and fiscal year ended March 28, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The foregoing information in this Item 2.02, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or o…
Director — Charles J. Dockendorff: Mr. Dockendorff will not stand for re-election at the 2026 Annual Meeting.
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.